Conor McNamara
Stock Analyst at RBC Capital
(1.22)
# 2,590
Out of 4,412 analysts
61
Total ratings
33.33%
Success rate
-12.4%
Average return
Main Sectors:
12 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ILMN Illumina | Reiterates: Outperform | $253 | $123.05 | +105.61% | 7 | Apr 9, 2024 | |
| OABI OmniAb | Reiterates: Outperform | $7 | $4.44 | +57.66% | 1 | Mar 21, 2024 | |
| SOPH SOPHiA GENETICS | Reiterates: Outperform | $8 | $5.10 | +56.86% | 3 | Mar 6, 2024 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Outperform | $12 → $14 | $8.20 | +70.73% | 4 | Feb 23, 2024 | |
| BIO Bio-Rad Laboratories | Maintains: Outperform | $484 → $480 | $269.75 | +77.94% | 5 | Feb 16, 2024 | |
| AVTR Avantor | Maintains: Outperform | $28 → $29 | $24.23 | +19.69% | 2 | Feb 15, 2024 | |
| QDEL QuidelOrtho | Maintains: Outperform | $130 → $81 | $40.55 | +99.75% | 7 | Feb 14, 2024 | |
| TECH Bio-Techne | Maintains: Sector Perform | $85 → $75 | $63.21 | +18.65% | 6 | Feb 2, 2024 | |
| TMO Thermo Fisher | Maintains: Outperform | $592 → $642 | $568.72 | +12.89% | 10 | Feb 1, 2024 | |
| DHR Danaher | Maintains: Outperform | $254 → $282 | $246.62 | +14.35% | 4 | Jan 31, 2024 | |
| HOLX Hologic | Maintains: Sector Perform | $74 → $72 | $75.77 | -4.98% | 5 | Nov 10, 2023 | |
| RGEN Repligen | Maintains: Outperform | $207 → $200 | $164.20 | +21.80% | 7 | Nov 1, 2023 |
Illumina
Apr 9, 2024
Reiterates: Outperform
Price Target: $253
Current: $123.05
Upside: +105.61%
OmniAb
Mar 21, 2024
Reiterates: Outperform
Price Target: $7
Current: $4.44
Upside: +57.66%
SOPHiA GENETICS
Mar 6, 2024
Reiterates: Outperform
Price Target: $8
Current: $5.10
Upside: +56.86%
Maravai LifeSciences Holdings
Feb 23, 2024
Maintains: Outperform
Price Target: $12 → $14
Current: $8.20
Upside: +70.73%
Bio-Rad Laboratories
Feb 16, 2024
Maintains: Outperform
Price Target: $484 → $480
Current: $269.75
Upside: +77.94%
Avantor
Feb 15, 2024
Maintains: Outperform
Price Target: $28 → $29
Current: $24.23
Upside: +19.69%
QuidelOrtho
Feb 14, 2024
Maintains: Outperform
Price Target: $130 → $81
Current: $40.55
Upside: +99.75%
Bio-Techne
Feb 2, 2024
Maintains: Sector Perform
Price Target: $85 → $75
Current: $63.21
Upside: +18.65%
Thermo Fisher
Feb 1, 2024
Maintains: Outperform
Price Target: $592 → $642
Current: $568.72
Upside: +12.89%
Danaher
Jan 31, 2024
Maintains: Outperform
Price Target: $254 → $282
Current: $246.62
Upside: +14.35%
Hologic
Nov 10, 2023
Maintains: Sector Perform
Price Target: $74 → $72
Current: $75.77
Upside: -4.98%
Repligen
Nov 1, 2023
Maintains: Outperform
Price Target: $207 → $200
Current: $164.20
Upside: +21.80%